Clinical trial
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis
NCT00005921 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00005921 |
|---|---|
| Title | A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis |
| Official title | An Open, Serial-Panel, Multiple-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of L-743,872 in Patients With Candida Esophagitis |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Candidiasis, Esophageal, HIV Infections |
| Intervention type | Drug |
| Interventions | L-743, 872 |
| Enrollment | 18 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: